WT1 and hepatocellular carcinoma: To investigate the association of WT1-AS expression with chemotherapeutic drug resistance, two HCC cell lines with a low expression of WT1-AS and a high expression of WT1 were treated with the commonly used chemotherapeutic drug doxorubicin (DOX).